Effects of Stochastic Whole-body Vibration Training on Balance and Executive Functions
NCT06629298, Not applicable, Completed, University of Bern
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Stochastic Whole-body Vibration Training on Balance and Executive Functions | ClinicalTrials.gov |
| NCT number | NCT06629298 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 62 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Bern | ClinicalTrials.gov |
| Conditions | Healthy | ClinicalTrials.gov |
| Interventions | 5Hz Stochastic Resonance Whole-Body Vibration Training, 2 Hz Stochastic Resonance Whole-Body Vibration Training | ClinicalTrials.gov |
| First posted | 2024-10-08 | ClinicalTrials.gov |
| Last updated | 2024-10-18 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Sense of Balance (Change from Baseline) | 19 min before and 19 min after the intervention (immediate effects) | Measured with subjective scale (sense of balance from 0 to 10) How do you assess your personal sensations regarding muscles and joints (back pain, shoulder and neck pain, leg muscle pain, etc.) at this moment? Please slide the scale for each aspect to the most appropriate level. 0 means no pain, and 10 means the most intense pain imaginable. | ClinicalTrials.gov |
| Primary | Balance (Change from Baseline) | Immediately before and 13 min after the intervention (immediate effects) | Measured with the modified star excursion balance test (m-SEBT). Higher values indicate better balance with 0cm being the minimum and ca. 100cm indicating very good balance, i.e. reach distance. In this balance test, participants stand on one leg, while the range of motion of the other leg is measured in eight directions: anterior (ANT), posteromedial (PM), and posterolateral (PL). (Duration: 5 min) | ClinicalTrials.gov |
| Secondary | Executive functions (Shifting) (Change from Baseline) | 10 min before and 8 min after the intervention (immediate effects) | Measured with the Trail-Making Test B For TMT B, participants were presented with circles filled with both numbers and letters. They were required to click the circles in ascending order, alternating between numbers and letters (e.g., 1, A, 2, B, 3, C). The practice task consisted of six circles, and the main test involved 24 circles. The processing time was measured in milliseconds. Thus, higher scores in the Trail-Making Test B indicate lower shifting ability. (Duration: 3 min) | ClinicalTrials.gov |
| Secondary | Executive functions (Updating) (Change from Baseline) | 18 min before and immediately after the intervention (immediate effects) | Measured with the Running Span-Task Participants were presented with a series of letters of varying lengths (3 to 8 letters). For each participant, both the total Running Span (sum of all correctly recalled target items) and the Running Span Score (sum of correctly recalled target items from sets that included at least one distractor) were calculated. Thus, higher scores (MIN = 0) in the Running Span-Task indicate higher updating ability. (Duration: 8 min) | ClinicalTrials.gov |
| Secondary | Executive functions (Inhibition) (Change from Baseline) | 7 min before and 11 min after the intervention (immediate effects) | Measured with the Stroop Test in milliseconds (Reaction Time) The reaction times (in milliseconds) for all correctly identified incongruent items were subtracted from those for control items. 0 ms indicate no cognitive interference, i.e. maximal inhibitory control Thus, higher scores in the Stroop Test indicate higher cognitive interference, i.e. poorer inhibitory control (Duration: 2 min) | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 36793620 | BACKGROUND | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Running Span | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)